<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392351</url>
  </required_header>
  <id_info>
    <org_study_id>S2333</org_study_id>
    <nct_id>NCT02392351</nct_id>
  </id_info>
  <brief_title>Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)</brief_title>
  <official_title>A Boston Scientific Clinical Trial of Renal Denervation Using the Vessix Reduce™ Catheter and Vessix™ Generator for the Treatment of HyperTensioN: REINFORCE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The REDUCE HTN: REINFORCE study is being conducted to determine whether the Vessix Reduce™
      Catheter and Vessix™ Generator for the treatment of uncontrolled hypertension (off-treatment
      office systolic blood pressure ≥150 mmHg and ≤180 mmHg) shows acceptable performance at 8
      weeks when compared to a masked procedure (renal angiogram).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter, single blinded, randomized, controlled, pilot study. Subjects will
      be randomized to renal denervation treatment or masked renal angiogram procedure (2:1).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean reduction in average 24-hour ambulatory systolic blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-Cause Death</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Failure</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypertensive crisis</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypotension/syncope</measure>
    <time_frame>Through 36mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant embolic event resulting in end-organ damage or intervention to prevent it</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal artery dissection or perforation requiring intervention</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular complications</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant new renal artery stenosis</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Office-based systolic blood pressure</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Office-based diastolic blood pressure</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of subjects at target blood pressure</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Congestive Heart Failure</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>Through 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of anti-hypertensive medications</measure>
    <time_frame>3mo, 6mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean reduction in average 24-hour ambulatory systolic blood pressure</measure>
    <time_frame>6mo, 12mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean reduction in average 24-hour ambulatory diastolic blood pressure</measure>
    <time_frame>6mo, 12mo</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Renal Denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous renal denervation using the Vessix Reduce™ Catheter and Vessix™ Generator (Vessix Renal Denervation System).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Masked Procedure</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Percutaneous renal angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal Denervation (Vessix)</intervention_name>
    <description>Percutaneous renal denervation using the Vessix Reduce™ Catheter and Vessix™ Generator</description>
    <arm_group_label>Renal Denervation</arm_group_label>
    <other_name>Vessix Reduce™ Catheter and Vessix™ Generator</other_name>
    <other_name>Vessix Renal Denervation System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal Angiography</intervention_name>
    <description>Percutaneous renal angiography</description>
    <arm_group_label>Masked Procedure</arm_group_label>
    <other_name>Renal Angiogram</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 and ≤75 years

          -  OSBP ≥150 mmHg and ≤180 mmHg based on an average of 3 office-based blood pressure
             measurements

          -  Average 24-hour ASBP ≥135 mmHg and ≤170 mmHg

          -  For each kidney, a main renal artery, with or without accessory renal arteries, with
             diameter ≥3.0 mm and ≤7.0 mm and length ≥20.0 mm

          -  Agrees to have all study procedures performed, and is competent and willing to provide
             written, informed consent

        Exclusion Criteria:

          -  Stenosis &gt;30% or renal artery aneurysm in either renal artery

          -  Fibromuscular dysplasia (FMD)

          -  Known causes of secondary HTN

          -  Type 1 diabetes mellitus

          -  eGFR &lt;40 mL/min/1.73m2

          -  Known ejection fraction of &lt;30% or heart failure that required hospitalization in the
             previous 6 months

          -  Severe valvular heart disease

          -  ≥1 episode(s) of orthostatic hypotension not related to medication changes (reduction
             of SBP of ≥20 mmHg or DBP of ≥10 mmHg within three minutes of standing) coupled with
             symptoms within the past year or during screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin B Leon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Weber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SUNY Downstate College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiology, PC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars - Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Institute of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aspirus Heart and Vascular Institute</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Renal Denervation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

